I'm LongbridgeAI, I can summarize articles.According to the announcement from Winshine Science (00209), the company proposes a rights issue on the basis of 7 rights shares for every 1 existing share held on the record date, at a subscription price of HKD 0.14 per rights share, to raise a total of approximately HKD 182 million by issuing up to about 1.3 billion rights shares to eligible shareholders (assuming no change in the number of shares issued on or before the record date).
The subscription price represents a discount of approximately 23.5% to the closing price of HKD 0.183 per share reported on the Stock Exchange on October 14, 2025.
Assuming the rights issue is fully subscribed, the estimated net proceeds from the rights issue will be approximately HKD 176.5 million (assuming no change in the number of shares issued on or before the record date)
